BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 32711434)

  • 1. Ki67, CD105, and α-SMA Expression Supports Biological Distinctness of Oral Squamous Cell Carcinoma Arising in the Background of Oral Submucous Fibrosis.
    Gadbail AR; Korde S; Chaudhary MS; Sarode SC; Gondivkar SM; Dande R; Tekade SA; Yuwanati M; Hande A; Patil S
    Asian Pac J Cancer Prev; 2020 Jul; 21(7):2067-2074. PubMed ID: 32711434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ki67, CD105 and α-smooth muscle actin expression in disease progression model of oral submucous fibrosis.
    Gadbail AR; Chaudhary MS; Sarode SC; Gondivkar SM; Belekar L; Mankar-Gadbail MP; Dande R; Tekade SA; Yuwanati MB; Patil S
    J Investig Clin Dent; 2019 Nov; 10(4):e12443. PubMed ID: 31325233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ki67, CD105, and α-SMA expression supports the transformation relevant dysplastic features in the atrophic epithelium of oral submucous fibrosis.
    Gadbail AR; Chaudhary M; Sarode SC; Gondivkar S; Tekade SA; Zade P; Hande A; Sarode GS; Patil S
    PLoS One; 2018; 13(7):e0200171. PubMed ID: 30001387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of microvessel density using CD34 and CD105 in oral submucous fibrosis and its correlation with clinicopathological features: An immunohistochemical study.
    Pammar C; Nayak RS; Kotrashetti VS; Hosmani J
    J Cancer Res Ther; 2018; 14(5):983-988. PubMed ID: 30197335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MALDI imaging reveals NCOA7 as a potential biomarker in oral squamous cell carcinoma arising from oral submucous fibrosis.
    Xie X; Jiang Y; Yuan Y; Wang P; Li X; Chen F; Sun C; Zhao H; Zeng X; Jiang L; Zhou Y; Dan H; Feng M; Liu R; Chen Q
    Oncotarget; 2016 Sep; 7(37):59987-60004. PubMed ID: 27509054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential expression of programmed death-1 and its ligand, programmed death ligand-1 in oral squamous cell carcinoma with and without oral submucous fibrosis.
    Quan H; Liu S; Shan Z; Liu Z; Chen T; Hu Y; Yao Z; Fang L
    Arch Oral Biol; 2020 Nov; 119():104916. PubMed ID: 32977151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ki67, CD105, and α-SMA expressions better relate the binary oral epithelial dysplasia grading system of World Health Organization.
    Gadbail AR; Chaudhary MS; Sarode SC; Gawande M; Korde S; Tekade SA; Gondivkar S; Hande A; Maladhari R
    J Oral Pathol Med; 2017 Nov; 46(10):921-927. PubMed ID: 28672080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Expression of PTPRZ1 in oral squamous cell carcinoma originated from oral submucous fibrosis and its clinical significance].
    Zhu R; Jian XC; Liu DY; Zhou C; Wang Y
    Shanghai Kou Qiang Yi Xue; 2017 Apr; 26(2):198-203. PubMed ID: 28815252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical biomarkers in oral submucous fibrosis: A scoping review.
    Kavitha L; Ranganathan K; Shyam S; Fathima JHS; Umesh W; Warnakulasuriya S
    J Oral Pathol Med; 2022 Aug; 51(7):594-602. PubMed ID: 35102645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular profiling of oral squamous cell carcinoma associated with oral submucous fibrosis.
    Choudhari S; Masne S; Bhandare P; Dhumal S
    J Cancer Res Ther; 2022; 18(1):55-65. PubMed ID: 35381762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of Ki67 Biomarker in Oral Submucous Fibrosis with Clinico-Pathological Correlations: A Prospective Study.
    Kamala KA; Kanetkar SR; Datkhile KD; Sankethguddad S
    Asian Pac J Cancer Prev; 2022 Jan; 23(1):253-259. PubMed ID: 35092395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical detection of p53 and p63 in oral squamous cell carcinoma, oral leukoplakia, and oral submucous fibrosis.
    Varun BR; Ranganathan K; Rao UK; Joshua E
    J Investig Clin Dent; 2014 Aug; 5(3):214-9. PubMed ID: 23776093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p16 as an independent marker for detection of high-risk HPV in oral submucous fibrosis and oral squamous cell carcinoma.
    Sudhakaran A; Hallikeri K; Babu B
    Indian J Pathol Microbiol; 2019; 62(4):523-528. PubMed ID: 31611434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression pattern of DKK3, dickkopf WNT signaling pathway inhibitor 3, in the malignant progression of oral submucous fibrosis.
    Zhou S; Zhu Y; Mashrah M; Zhang X; He Z; Yao Z; Zhang C; Guo F; Hu Y; Zhang C
    Oncol Rep; 2017 Feb; 37(2):979-985. PubMed ID: 27959428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of HIF-1α and CD105 in establishing oral squamous cell carcinoma associated with oral submucous fibrosis a distinct clinicopathological entity.
    Hande AH; Chaudhary MS; Gadbail AR; Gawande MN; Patil SK; Zade PR; Sharma PN; Jaiswal SG; Sonone AM
    J Cancer Res Ther; 2022; 18(1):33-41. PubMed ID: 35381759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and promoter methylation of Wnt inhibitory factor-1 in the development of oral submucous fibrosis.
    Zhou S; Chen L; Mashrah M; Zhu Y; He Z; Hu Y; Xiang T; Yao Z; Guo F; Zhang C
    Oncol Rep; 2015 Nov; 34(5):2636-42. PubMed ID: 26352791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical Expression of CD105 and TGF-β1 in Oral Squamous Cell Carcinoma and Adjacent Apparently Normal Oral Mucosa and its Correlation With Clinicopathologic Features.
    Nair S; Nayak R; Bhat K; Kotrashetti VS; Babji D
    Appl Immunohistochem Mol Morphol; 2016 Jan; 24(1):35-41. PubMed ID: 25710582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ki67 Labelling Index predicts clinical outcome and survival in oral squamous cell carcinoma.
    Gadbail AR; Sarode SC; Chaudhary MS; Gondivkar SM; Tekade SA; Yuwanati M; Patil S
    J Appl Oral Sci; 2021; 29():e20200751. PubMed ID: 33656066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased expression of CK8 and CK18 in leukoplakia, oral submucous fibrosis, and oral squamous cell carcinoma: an immunohistochemistry study.
    Nanda KD; Ranganathan K; Devi U; Joshua E
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2012 Feb; 113(2):245-53. PubMed ID: 22677743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of α-enolase as a prognostic and diagnostic precancer biomarker in oral submucous fibrosis.
    Bag S; Dutta D; Chaudhary A; Sing BC; Pal M; Ray AK; Banerjee R; Paul RR; Basak A; Das AK; Chatterjee J
    J Clin Pathol; 2018 Mar; 71(3):228-238. PubMed ID: 28821582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.